114 FINAL RESULTS OF PHASE II RANDOMIZED TRIAL OF AZACITIDINE VERSUS SUPPORT TREATMENT IN PATIENTS WITH LOW RISK MYELODYSPLASTIC SYNDROME WITHOUT THE 5Q DELETION. (April 2015) - Sanchez-Garcia, J.; Falantes, J.; Medina, A.; Hernandez-Mohedo, F.; Torres-Sabariego, A.; Bailen, A.; Sole, M.; Casaño, J.; Calderon, C.; Hermosin, L.; Vahi, M.; Serrano, J.